I'd say I haven't documented the Fauxci/Pfizer connection but documented the Moderna/Fauxci connection.
However I will locate the Fauxci/Pfizer connection, believe he gets a royalty. Until I post that, we will only attribute his patent connection with Moderna. Still that's a problem when your agency has a profit interest in Moderna and the same agency is restricting J&J from the market. It's like self dealing.
Market Data 
Markets 
AI
